Medcorp Limited (TTSE:MED)
Trinidad and Tobago
· Delayed Price · Currency is TTD 44.00
0.00 (0.00%)
At close: Apr 27, 2026
Medcorp Income Statement
Financials in millions TTD. Fiscal year is January - December.
Millions TTD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 121.7 | 122.24 | 127.02 | 122.22 | 114.19 | Upgrade
|
| Revenue Growth (YoY) | -0.44% | -3.76% | 3.92% | 7.03% | 10.46% | Upgrade
|
| Cost of Revenue | 60.03 | 59.68 | 56 | 61.81 | 56.05 | Upgrade
|
| Gross Profit | 61.67 | 62.55 | 71.02 | 60.41 | 58.14 | Upgrade
|
| Selling, General & Admin | 41.04 | 38.64 | 33.24 | 32.08 | 28.4 | Upgrade
|
| Other Operating Expenses | -1.68 | 0.55 | -1.66 | -3.19 | -5.25 | Upgrade
|
| Operating Expenses | 39.36 | 39.19 | 31.59 | 28.89 | 23.15 | Upgrade
|
| Operating Income | 22.31 | 23.36 | 39.43 | 31.52 | 34.99 | Upgrade
|
| Interest Expense | -4.34 | -5.95 | -3.21 | -2.45 | -2.31 | Upgrade
|
| Interest & Investment Income | - | - | 30.69 | - | - | Upgrade
|
| Earnings From Equity Investments | 2.45 | 4.83 | 4.98 | 1.72 | 1.99 | Upgrade
|
| EBT Excluding Unusual Items | 20.42 | 22.24 | 71.89 | 30.79 | 34.66 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0 | 0.12 | - | Upgrade
|
| Pretax Income | 20.42 | 22.24 | 71.89 | 30.91 | 34.66 | Upgrade
|
| Income Tax Expense | 2.24 | 6.86 | 14.82 | 6.78 | 10.17 | Upgrade
|
| Net Income | 18.18 | 15.38 | 57.07 | 24.13 | 24.49 | Upgrade
|
| Net Income to Common | 18.18 | 15.38 | 57.07 | 24.13 | 24.49 | Upgrade
|
| Net Income Growth | 18.21% | -73.05% | 136.53% | -1.49% | 38.74% | Upgrade
|
| Shares Outstanding (Basic) | 8 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | 2.34% | - | - | - | - | Upgrade
|
| EPS (Basic) | 2.37 | 2.06 | 7.63 | 3.23 | 3.27 | Upgrade
|
| EPS (Diluted) | 2.37 | 2.06 | 7.63 | 3.23 | 3.27 | Upgrade
|
| EPS Growth | 15.51% | -73.05% | 136.53% | -1.49% | - | Upgrade
|
| Free Cash Flow | 22.76 | 20.12 | 28.71 | 25.41 | 5.66 | Upgrade
|
| Free Cash Flow Per Share | 2.97 | 2.69 | 3.84 | 3.40 | 0.76 | Upgrade
|
| Dividend Per Share | 2.000 | 4.000 | - | - | 4.500 | Upgrade
|
| Dividend Growth | -50.00% | - | - | - | - | Upgrade
|
| Gross Margin | 50.67% | 51.17% | 55.92% | 49.43% | 50.91% | Upgrade
|
| Operating Margin | 18.33% | 19.11% | 31.05% | 25.79% | 30.64% | Upgrade
|
| Profit Margin | 14.94% | 12.58% | 44.93% | 19.74% | 21.45% | Upgrade
|
| Free Cash Flow Margin | 18.70% | 16.46% | 22.60% | 20.79% | 4.96% | Upgrade
|
| EBITDA | 27.05 | 28.55 | 44.62 | 36.67 | 36.91 | Upgrade
|
| EBITDA Margin | 22.23% | 23.36% | 35.13% | 30.00% | 32.32% | Upgrade
|
| D&A For EBITDA | 4.74 | 5.19 | 5.18 | 5.14 | 1.92 | Upgrade
|
| EBIT | 22.31 | 23.36 | 39.43 | 31.52 | 34.99 | Upgrade
|
| EBIT Margin | 18.33% | 19.11% | 31.05% | 25.79% | 30.64% | Upgrade
|
| Effective Tax Rate | 10.96% | 30.86% | 20.62% | 21.94% | 29.34% | Upgrade
|
| Advertising Expenses | 0.28 | 0.24 | 0.17 | 0.2 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.